International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–3
- Moderate Risk3.5–6
- High Risk6.5–20
The International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include diabetes type. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Stratifies risk of fasting during Ramadan in diabetic patients using validated clinical parameters. The IDF-DAR tool provides evidence-based guidance for healthcare providers and patients to make informed decisions about the safety of fasting during Ramadan based on diabetes type, glycemic control, complications, and other risk factors.
Clinical Indication
The International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment is indicated for bedside clinical practice to support Stratifies risk of fasting during Ramadan in diabetic patients using validated clinical parameters. The IDF-DAR tool provides evidence-based guidance for healthcare providers and patients to make informed decisions about the safety of fasting during Ramadan based on diabetes type, glycemic control, complications, and other risk factors.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Risk Score = Diabetes Type + Years Since Diagnosis + Hypoglycemia Score + HbA1c Score + Treatment Score + Monitoring Score + Complication Scores + Social Factors
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| diabetes_type | string | Yes | Type of diabetes mellitus. Type 1 diabetes carries higher baseline fasting risk due to insulin dependence and greater glycemic variability |
| years_since_diagnosis | string | Yes | Duration of diabetes diagnosis. Longer duration associated with increased risk of complications and glucose variability(years) |
| hypoglycemia_frequency | string | Yes | Frequency and severity of hypoglycemic episodes. Recent severe hypoglycemia or hypoglycemia unawareness significantly increases fasting risk |
| hba1c_level | string | Yes | Glycemic control measured by HbA1c. Poor control (>9%) indicates higher risk of acute complications during fasting(%) |
| treatment_type | string | Yes | Current diabetes treatment regimen. Insulin therapy and certain sulfonylureas increase hypoglycemia risk during fasting |
| self_monitoring_frequency | string | Yes | Blood glucose self-monitoring frequency. Regular monitoring enables safer fasting through early detection of glucose abnormalities |
| acute_complications | string | Yes | History of acute diabetic complications including diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) within the past 3 months |
| macrovascular_disease | string | Yes | Presence of macrovascular complications including coronary artery disease, cerebrovascular disease, or peripheral arterial disease |
| renal_complications | string | Yes | Diabetic nephropathy or chronic kidney disease stage 4-5 (eGFR <30 mL/min/1.73m²) |
| pregnancy_status | string | Yes | Pregnancy or breastfeeding status. Pregnant and breastfeeding women with diabetes are generally advised against fasting |
| frailty_cognitive_function | string | Yes | Frailty or cognitive impairment that may impair ability to recognize or respond to hypoglycemia symptoms |
| physical_labor | string | Yes | Occupation involving intense physical labor or activity that increases metabolic demands and hypoglycemia risk during fasting |
| previous_ramadan_experience | string | Yes | Experience with previous Ramadan fasting. Prior successful fasting may indicate better tolerance and risk management |
| fasting_hours | string | Yes | Duration of daily fasting hours based on geographic location and season. Longer fasting periods increase dehydration and hypoglycemia risk(hours) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | Low Risk | Fasting probably safe |
| 3.5–6 | Moderate Risk | Fasting safety uncertain |
| 6.5–20 | High Risk | Fasting probably unsafe |
Evidence-Based References (EBM)
- Hassanein M, Sahay BK, Hafidh K, Djaballah K, Li H, Rahim MA, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract. 2022 Mar;185:109185. doi: 10.1016/j.diabres.2021.109185.DOI: 10.1016/j.diabres.2021.109185
- Ibrahim M, Al Magd MA, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2020, applying evidence from a decade of research. BMJ Open Diabetes Res Care. 2020 May;8(1):e001248. doi: 10.1136/bmjdrc-2020-001248.DOI: 10.1136/bmjdrc-2020-001248
- Alam F, Oubari S, Ahmad J, Eba-Alkhayri A, Almadani A, Babineaux S, et al. Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus. Saudi Med J. 2024 Jan;45(1):86-92. doi: 10.15537/smj.2024.45.1.20230497.DOI: 10.15537/smj.2024.45.1.20230497